ZYVERSA THERAPEUTICS, INC. Impairment of Intangible Assets (Excluding Goodwill)
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Impairment of Intangible Assets (Excluding Goodwill) of $81.44 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2025-03-27
- ZYVERSA THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-12-31 was $12.16M.
- ZYVERSA THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-09-30 was $0.00.
- ZYVERSA THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-06-30 was $69.28M.
- ZYVERSA THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2023 was $81.44M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $12.16M derived: sum of 2 quarters · filed 2025-03-27 | $81.44M derived: sum of 3 quarters · filed 2025-03-27 | $81.44M 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $69.28M derived: sum of 2 quarters · filed 2024-11-14 | $69.28M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $69.28M 10-Q · filed 2024-08-09 | $69.28M 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |